By Spencer Osborne : Arena Pharmaceuticals' (NASDAQ: ARNA ) anti-obesity pill Belviq saw a full recovery from a holiday dip in sales last week with a 15% gain this week. Sales in the most recent week demonstrated a full recovery plus a modest increase above the pre-holiday sales levels. The rise ...
in excess of a billion dollars per year. Qsymia will compete with Belviq by Arena (NASDAQ: ARNA ). Orexigen's (NASDAQ: OREX ) drug was recently approved by the FDA, with the requirement for more safety trials like Qysimia. Discussion of the earnings
By SA Transcripts : Orexigen Therapeutics , Inc. (NASDAQ: OREX ) Bank of America Merrill Lynch Global Healthcare Conference September 18, 2014 11:10 AM ET Executives Mark Booth - CCO McDavid
By Long Term Bio : Orexigen Therapeutics (NASDAQ: OREX ) received FDA approval for their obesity drug Contrave ..... to give to patients to help reduce their weight. Orexigen Therapeutics has been struggling to receive FDA approval for Contrave
By Spencer Osborne : Orexigen (NASDAQ: OREX ) shares have tumbled upon FDA approval of the anti-obesity drug Contrave. This type of market reaction may not be what some
By R.S. Analytics : Orexigen's (NASDAQ: OREX ) obesity drug, Contrave, finally received FDA approval last Thursday. Unfortunately for Orexigen longs, Arena Pharmaceutical
By Spencer Osborne : Novo Nordisk (NYSE: NVO ) received good news earlier this week in its quest to get an obesity indication for its drug Saxenda. The drug is a different dose (3mg) form of liaglutide that would be injected once a day for patienmts seeking to treat obesity. The FDA's ...
By Alexander Maxwell : Orexigen Therapeutics (NASDAQ: OREX ) investors were finally rewarded for their patience, after obtaining FDA approval for Orexigen's weight-loss drug Contrave
Labor Day weekend and preempted the announcement regarding the approval of a competing drug, Contrave, from Orexigen (NASDAQ: OREX ). During the week of September 1st through September 7th Belviq was advertised just 136 times but was in time slots that had
By Fredrik Arnold : Weary of Wall Street Wizard Weights? Are you sick and tired of the same old dreary record-breaking numbers being reported for the DowJones30; S&P500; NASDAQ100; RUSSELL3000; BARRON400; ValueLineXYZ; Etc.; Etc.? Here's the cure. It's a patriotic collection of stocks selected by